Crossmark

Price and affordability of direct-acting antiviral regimens for hepatitis C virus in the United States

Published Online: 2016-05-16

Published Print: 2016-12

Authors

Rosenthal, Elana S.

Graham, Camilla S.
Funding

Funding for this research was provided by:

National Cancer Institute (HHSN261200800001E)
License Information

Text and Data Mining valid from 2016-05-16

Version of Record valid from 2016-05-16
More Information

Article History

Received: 11 November 2015

Accepted: 30 March 2016

First Online: 16 May 2016

Document is current